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A scalable biomanufacturing platform is crucial to meet the anticipated demands for off-the-shelf cell therapy 
products. Growing cells on microcarriers or in aggregates suspended in bioreactors is the most promising option 
for scaling up, however minimizing cell damage due to hydrodynamic shear is one of the main challenges for 
large scale cell culture processes. 
 
PBS Vertical-WheelTM single-use bioreactors suspend microcarriers and cell aggregates with significantly less 
shear than conventional stirred bioreactors, minimizing risks during scale up. Both hydrodynamic and adult stem 
cell biological data will be presented showing equivalent biological performance in working volumes from 0.5 to 50 
L. PBS Biotech is also announcing ENABLETM contract process development and scale up services for cell 
therapy customers. Time permitting, newly available pluripotent stem cell culture and differentiation data will also 
be shared.  
 
 
